BioAdaptives, Inc. (OTC: BDPT) is engaged in the research
and development of science-based nutraceutical products for human and animal
consumption. By sourcing high quality raw materials, the company is able to
develop innovative products designed to improve overall health and wellness by
providing a collection of benefits ranging from improved cognition and focus to
reduced fatigue. BioAdaptives also owns exclusive rights to a non-invasive
bioelectromagnetic device that has been shown to improve the effectiveness of
individual ingredients, clearing the way for higher quality products that meet
the unique needs of the nutraceutical industry.
In June, BioAdaptives took a significant step toward
financial growth through the announcement of a nationwide product roll-out,
which is expected to take place in the third quarter of 2015. The company
highlighted five products to be offered as part of this release – including
PrimiCell®, a scientifically-proven stem cell activator; PrimiLive™, which
provides stress-relief and energy without stimulants; PrimiTrim™, an effective
natural weight management product; Equine Regen Plus™, an all-encompassing
multi-faceted equine wellness product for performance horses; and Canine
Regen™, an effective supplement for canine stem cell health and wellness.
BioAdaptives’s development pipeline also includes additional products currently
being tested, which are expected to be released later this year.
“It’s been a long and rewarding process to develop these
products,” Barry Epling, chairman of BioAdaptives, stated in a news release.
“We are genuinely excited about the prospects to improve the overall wellness
of our customers.”
Following the release of its initial product line,
BioAdaptives will be in a favorable position to capitalize on the strong
performance of the global nutraceuticals market. According to a report from
MarketsandMarkets, the market for nutraceutical ingredients is projected to
climb to approximately $38.7 billion by 2020, realizing a compound annual
growth rate of about 7.2 percent for the next five years. Moving forward, the
company will look to establish itself as a leading supplier of quality
nutraceutical products in a collection of developed countries with aging
populations while continuing to create new and innovative products that
generate growth in both sales and profitability.
With its initial product roll-out scheduled to occur by the
end of the quarter, it’s an exciting time for prospective shareholders of
BioAdaptives. Look for the company to continue making progress toward
increasing its market share and promoting sustainable financial growth in the
months to come.
For more information, visit www.bioadaptives.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment